K983066 · Teftec Corp. · ITI · Nov 27, 1998 · Physical Medicine
Device Facts
Record ID
K983066
Device Name
FIRSTCLASS POWER TILT SEAT SYSTEM, MODEL S300
Applicant
Teftec Corp.
Product Code
ITI · Physical Medicine
Decision Date
Nov 27, 1998
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 890.3860
Device Class
Class 2
Attributes
Therapeutic
Indications for Use
The TEFTEC Corporation FirstClass™ Power Tilt Seating System has been designed for use by anyone needing pressure relief while in a seated position. The First Class™ Power Tit Seating System could provide pressure relief by postural change for persons having the following condition or injury: Spinal Cord Injury (SCI) Head Injury (CHI) Muscular Dystrophy (MD) Cerebral Palsy (CP) Hyper Reflexia Chronic Pain Burn Trauma Patient Severe Scar Tissue build up Brown Sequard's Syndrome Multiple Scierosis Heterotrophic Ossification Traumatic Brain Injury (TBI) Amyotrophic Lateral Sclerosis (ALS) Quadriplegia Cerebral Palsy Paraplegia Proximal Extremity Weakness Cerebral Vascular Accident (CVA or Stroke) This is not meant to be an all-inclusive list. Anyone needing pressure relief or positional change that is unable to facilitate those movements independently, would be able to accomplish them with this unit. This would usually be decided by clinical evaluation of the client's strength, sensation level, upper extremity strength, mobility needs and seating needs.
Device Story
FirstClass™ Power Tilt Seat System Model S300 is a powered seating system designed to provide pressure relief through postural change. The device is intended for patients unable to independently shift weight or reposition while seated. It functions as an assistive mobility accessory, allowing users to tilt the seat to redistribute pressure, thereby potentially reducing the risk of pressure sores or complications associated with prolonged immobility. The system is operated by the user or a caregiver to adjust seating angles. It is used in clinical or home environments to facilitate positional changes based on a clinician's assessment of the patient's strength, sensation, and mobility requirements.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Powered tilt seating system; electromechanical actuation for postural adjustment. Designed for integration with seating platforms. Class II device (Product Code: ITI).
Indications for Use
Indicated for individuals requiring pressure relief or postural change while seated due to inability to perform movements independently. Applicable to patients with conditions including SCI, TBI, MD, CP, CVA, ALS, chronic pain, burn trauma, or other mobility/seating needs determined by clinical evaluation.
Regulatory Classification
Identification
A powered wheelchair is a battery-operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.
Related Devices
K992627 — FIRST CLASS POWER RECLINE SEATING SYSTEM, MODEL S500 · Teftec Corp. · Oct 25, 1999
K992628 — FIRSTCLASS POWER TILT AND RECLINE SEAT SYSTEM, MODEL S400 · Teftec Corp. · Oct 25, 1999
K994072 — AMYSYSTEMS PTS50CG 50 DEGREE WEIGHT SHIFT POWER TILT SYSTEM · Amylior, Inc. · Jan 13, 2000
K994107 — AMYSYSTEMS PTS50-50 DEGREE POWER TILT SYSTEM FOR MID-WHEEL OR FRONT-WHEEL DRIVE POWER WHEELCHAIRS. · Amylior, Inc. · Jan 13, 2000
K113577 — MERITS MODEL R SERIES POSITIONING SYSTEM FOR POWERED WHEELCHAIR · Merits Health Products Co., Ltd. · May 8, 2012
Submission Summary (Full Text)
{0}------------------------------------------------
NOV 2 7 1998
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Thomas E. Finch, III Vice President Teftec Corporation 6929 Old Spring Branch Road Spring Branch, Texas 78070
Re: K983066 FirstClass™ Powered Tilt Seat Trade Name: System, Model S300 Requlatory Class: II Product Code: ITI Dated: August 19, 1998 September 2, 1998 Received:
Dear Mr. Finch:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
{1}------------------------------------------------
Page 2 - Mr. Thomas E. Finch, III
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Director
Division of General and
Restorative Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure
{2}------------------------------------------------
Page 1 of 1
## 510 (k) NUMBER (IF KNOWN): K983066
DEVICE NAME:
FirstClass™ Power Tilt Seat System Model \$300
INDICATIONS FOR USE:
The TEFTEC Corporation FirstClass™ Power Tilt Seating System has been designed for use by anyone needing pressure relief while in a seated position.
The First Class™ Power Tit Seating System could provide pressure relief by postural change for persons having the following condition or injury:
Spinal Cord Injury (SCI) Head Injury (CHI) Muscular Dystrophy (MD) Cerebral Palsy (CP) Hyper Reflexia Chronic Pain Burn Trauma Patient Severe Scar Tissue build up Brown Sequard's Syndrome Multiple Scierosis Heterotrophic Ossification Traumatic Brain Injury (TBI) Amyotrophic Lateral Sclerosis (ALS) Quadriplegia Cerebral Palsy Paraplegia Proximal Extremity Weakness Cerebral Vascular Accident (CVA or Stroke)
This is not meant to be an all-inclusive list. Anyone needing pressure relief or positional change that is unable to facilitate those movements independently, would be able to accomplish them with this unit. This would usually be decided by clinical evaluation of the client's strength, sensation level, upper extremity strength, mobility needs and seating needs.
## (Please Do Not Write Below This Line-Continue On Another Page If Needed.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use<br>(Per 21 CFR 801.109) | OR Over-The-Counter-Use |
|------------------------------------------|----------------------------|
| | (Optional Format 1 2 - 96) |
| Revised 11/13/1998 | (Division/Sign-Off) |
|--------------------|-----------------------------------------|
| | Division of General Restorative Devices |
| 510(k) Number | K983066 |
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.